Stay Updated with the Latest BeOne Medicines AG ONC News in Real Time
Find ONC news now at Meyka AI. Stay informed with the latest BeOne Medicines AG stocks updates, including price news, market analysis, and expert insights.
Novo Nordisk (NYSE: NVO) Sues Eli Lilly (NYSE: LLY) Over Allegedly Misleading GLP-1 Drug Advertising
On 21 July 2026, Novo Nordisk (NYSE: NVO) filed a lawsuit against Eli Lilly (NYSE: LLY), accusing its rival of misleading consumers through advertising that compares their blockbuster GLP-1 weight-loss drugs. The legal dispute comes as demand for obesity treatments keeps rising and competition between the two drugmakers becomes more intense. The outcome could affect…
US, EU, and Global Aid Flows Into Venezuela After Devastating 7.5 Earthquakes
Venezuela earthquakes on June 24 killed 4,700+ and displaced 21,000. US, EU, and global partners now delivering food, medical aid, and shelter to 40,000+ families through NGOs and military operations.
Dr Reddy’s (NSE: DRREDDY) Shares Tumble 7% After Semaglutide Launch Delay Due to API Quality Issue
Dr Reddy’s Laboratories shares tumbled nearly 7% on Thursday, July 9, 2026, on the NSE. The Hyderabad-based drugmaker disclosed a quality issue affecting its semaglutide active pharmaceutical ingredient. Certain batches were found out of specification, delaying commercial supplies indefinitely. Shares fell as much as 6.5% to an intraday low of ₹1,261.20 on the BSE. That…
Marksans Pharma (NSE: MARKSANS) Rises Nearly 4% After Acquiring Germany’s ABCnow GmbH
On July 8, 2026, Marksans Pharma (NSE: MARKSANS) climbed nearly 4% after announcing the acquisition of Germany-based ABCnow GmbH. The deal comes only weeks after the company’s expansion into the Netherlands and reflects its continued focus on growing in regulated international markets. Investors are now watching whether these overseas acquisitions will increase revenue, widen the…
Craneware (LON:CRW) Shares Plunge 23% to Lowest Level Since 2016 After Cutting FY Revenue Outlook
Craneware plc shares fell as much as 23% today, touching an intraday low of 988 pence. That marks the stock’s lowest level since November 28, 2016. The Edinburgh-based healthcare financial software firm issued an unscheduled trading update warning that full-year results would miss market expectations. Craneware now guides FY26 revenue to $205 million to $208…
AbbVie to Acquire Apogee Therapeutics in $10.9 Billion Deal, Offering Nearly 50% Premium
AbbVie made a major move in the biotech sector on June 22, 2026, announcing a $10.9 billion deal to acquire Apogee Therapeutics. The transaction offers Apogee shareholders nearly a 50% premium and gives AbbVie access to a promising pipeline of immunology treatments. As competition grows in the market for inflammatory disease therapies, this acquisition could…
Traws Pharma Stock Drops 17% After UK Regulator Delays Flu Drug Trial
One regulatory hold is a setback. Two is a pattern, and Traws Pharma is now facing exactly that. On June 12, 2026, Traws Pharma (NASDAQ: TRAW) announced that its planned Phase 2a human influenza challenge study of tivoxavir marboxil (TXM) has been deferred following a negative review by the UK’s Medicines and Healthcare Products Regulatory…
Sun Pharmaceutical (SUNPHARMA) Shares Rise 0.32% as Pharma Giant Announces ₹5 Final Dividend Record Date
Sun Pharmaceutical Industries has once again grabbed investor attention in the Indian stock market. The Sun Pharmaceutical share price rose around 0.32% in recent trading sessions after the company announced a ₹5 final dividend for FY2025-26. The announcement also included key corporate updates, including the upcoming record date for dividend eligibility, which is now in…
Camurus Falls 7% as FDA Requests Reinspection for Oclaiz Approval
Shares of Camurus came under pressure after reports of a regulatory setback tied to its drug candidate Oclaiz. The stock dropped nearly 7% as investors reacted to news that the U.S. Food and Drug Administration (FDA) had requested a reinspection during the approval process. This development has created short-term uncertainty in the market. We from…